Treadmill Training in Fragile X-associated Tremor/Ataxia Syndrome
NCT04428567 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2021-10-28
Summary
A pilot trial to determine the feasibility of treadmill training with dual training in patients with Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).
Conditions
- Fragile X Associated Tremor-ataxia Syndrome
Interventions
- BEHAVIORAL
-
Dual-Task Treadmill exercise + Cognitive Training
The dual-task regimen will include treadmill exercise of 5-10 min warm-up and cool-down, 30 minutes of running towards target heart rate, combined with respond demands with the addition of cognitive tasks. The level of duration and intensity of treadmill exercise will progressively increase over the duration of 6 weeks.
Sponsors & Collaborators
-
Rush University Medical Center
lead OTHER
Principal Investigators
-
Joan A O'Keefe, PhD, PT · Rush University Medical Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-30
- Primary Completion
- 2020-03-30
- Completion
- 2020-03-30
Countries
- United States
Study Locations
More Related Trials
-
A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia
NCT06874010 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone
NCT02603926 ·Status: COMPLETED ·Phase: PHASE2
-
Coronary Artery Disease in Patients With Friedreich's Ataxia
NCT04649866 ·Status: COMPLETED ·Phase: NA
-
A First in Human Study of RT001 in Patients With Friedreich's Ataxia
NCT02445794 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
NCT01728064 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients
NCT03917225 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
NCT01035671 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia
NCT05573698 ·Status: COMPLETED ·Phase: PHASE1
-
Methylprednisolone Treatment of Friedreich Ataxia
NCT02424435 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside
NCT06324877 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of Resveratrol as Treatment for Friedreich Ataxia
NCT01339884 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
NCT00803868 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia
NCT04519567 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
NCT01898884 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of SGT-212 Gene Therapy in Friedreich's Ataxia
NCT07180355 ·Status: RECRUITING ·Phase: PHASE1
-
Acetazolamide Efficacy in Ataxia in PMM2-CDG
NCT04679389 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia
NCT03214588 ·Status: COMPLETED ·Phase: PHASE2
-
TCA Cycle in the Dentate in Friedreich's Ataxia
NCT03122925 ·Status: COMPLETED
-
An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
NCT01921868 ·Status: UNKNOWN ·Phase: NA
-
(+) Epicatechin to Treat Friedreich's Ataxia
NCT02660112 ·Status: COMPLETED ·Phase: PHASE2
-
A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
NCT06673056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy Study of Epoetin Alfa in Friedreich Ataxia
NCT01493973 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects
NCT00249704 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
NCT05285540 ·Status: COMPLETED ·Phase: PHASE1
-
Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia
NCT01776164 ·Status: COMPLETED